RUNA digital repository

    • Español
    • Galego
    • English
  • English 
    • Español
    • Galego
    • English
  • Login
RUNABibliosaúdeXunta de galicia. Consellería de sanidadeServicio Galego de saúde
  • REPOSITORY
  • ABOUT US
    • About RUNA
    • Normative
    • Sergas Policy
  • HELP
    • Help
    • FAQ
  •   RUNA Home
  • Scientific publication
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

TIPICO IX: report of the 9(th) interactive infectious disease workshop on infectious diseases and vaccines

Martinón Torres, Federico; Bosch, X.; Rappuoli, R.; Ladhani, S.; Redondo, E.; Vesikari, T.; Garcia-Sastre, A.; Rivero-Calle, I.; Gomez-Rial, J.; Salas, A.; Martin, C.; Finn, A.; Butler, R.
Thumbnail
Statistics
Statistics
View Usage Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/15682
PMID: 31158041
DOI: 10.1080/21645515.2019.1609823
ISSN: 2164-5515
Full record
Services
Services
RISMendeleyLinksolver
Files view or download
Files view or download
Hum Vaccin Immunother. 2019;15(10):2405-2415. doi: 10.1080/21645515.2019.1609823. Epub 2019 Jun 3. (1.156Mb)
Date issued
2019
Journal title
Human Vaccines & Immunotherapeutics 
Type of content
Artigo
DeCS
congresos como asunto | ensayos clínicos como asunto | enfermedades transmisibles | vacunas | humanos
MeSH
Clinical Trials as Topic | Congresses as Topic | Humans | Communicable Diseases | Vaccines
Abstract
The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22-23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.

Browse

All of RUNACollectionsCentersAuthorsTitlesDeCSMeSHCIETypes of contentThis CollectionCentersAuthorsTitlesDeCSMeSHCIETypes of content

Statistics

View Usage Statistics

OF INTEREST

About Open AccessCopyright
TwitterRSS
Xunta de Galicia
© Xunta de Galicia. Información mantida e publicada na internet pola Consellería de Sanidade o Servizo Galego de Saúde
Legal warning | RSS
Galicia